CUSIP: 03767D108
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,868,235
-
Share change
-
+307,903
-
Total reported value
-
$109,018,000
-
Put/Call ratio
-
0%
-
Price per share
-
$3.65
-
Number of holders
-
57
-
Value change
-
-$1,497,635
-
Number of buys
-
29
-
Number of sells
-
35
Quarterly Holders Quick Answers
What is CUSIP 03767D108?
CUSIP 03767D108 identifies APEN - APOLLO ENDOSURGERY INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP 03767D108:
Institutional Holders of APOLLO ENDOSURGERY INC - COM (APEN) as of Q2 2022
As of 30 Jun 2022,
APOLLO ENDOSURGERY INC - COM (APEN) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,868,235 shares.
The largest 10 holders included
CPMG Inc, Nantahala Capital Management, LLC, Soleus Capital Management, L.P., Stonepine Capital Management, LLC, GAGNON SECURITIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), CITIGROUP INC, VANGUARD GROUP INC, Gagnon Advisors, LLC, and SILVERARC CAPITAL MANAGEMENT, LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.